Mylan Pharmaceuticals’ attempt to explain the $600 price tag for life-saving allergy drug EpiPen hasn’t satisfied a leading Republican senator.
Sen. Chuck Grassley blasted Mylan for insufficient answers to a series of questions he gave the drug maker about the EpiPen price hike. Grassley is part of a slew of lawmakers starting probes into the hike.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.
